Skip to main content
. 2021 Jun 5;2:100032. doi: 10.1016/j.rcsop.2021.100032

Table 1.

Data overview.

Aim Data type Indicators Data Source Purpose Collected from Timeline
Aim 1 Administrative Data SDOH service implementation progress and outputs (e.g., rates of SDOH interventions) Spreadsheet To monitor progress and outputs Pharmacist Throughout the implementation period
Aim 2 Surveys Clinic Satisfaction Satisfaction Survey (created for study, alpha = 0.96; 3 items; 6-point scale, from “strongly disagree” to “strongly agree”) To assess satisfaction of the clinic team members with the service Clinic liaisons, staff and providers (N = 11/16, or response rate = 69%) After the first 3 months of implementation
Perceived Benefits Perceived Benefits Survey1 (4 items; 6-point scale, from “strongly disagree” to “strongly agree”) To assess perceived benefits of the service from the clinics' perspective
Service Acceptability Service Acceptability Measure from IOQ2 (7 items; 6-point scale, from “strongly disagree” to “strongly agree”) To assess acceptability of the service from the clinics' perspective
Service Appropriateness Service Appropriateness Measure from IOQ2 (6 items, response range from 1 to 5, from “not at all” to “extremely”) To assess integration and alignment of the service with the clinic and its practice
Service Feasibility Adapted Service Feasibility Survey from IOQ2(7 items; 6-point scale, from “strongly disagree” to “strongly agree”) To assess practicality of implementing the service
Patient Satisfaction/Experience Adapted Patient Satisfaction/Experience3 (Satisfaction: 1 item; 5-point scale, from “very poor” to “excellent”; Experience: 14 items; 5-point scale from "strongly disagree" to "stronly agree") To assess patient satisfaction and experience with the pharmacist and visits Patients (N = 10/12 or response rate = 83%) At end of the implementation period
Interviews Clinics' overall experience with the service Interview transcripts To assess the clinics' overall experience with the telepharmacy service Clinic liaisons (N = 3/3 or response rate = 100%) After the first 3 months of implementation
Aim 3 Surveys Patient Quality of life Adapted from Diabetes Quality of Life Survey4 (satisfaction with diabetes control: 6 items, 5-point scale, from “very dissatisfied” to “very satisfied”; and adherence to self-care regimen: 3 items, 5-point scale, from “never” to “all the time”) To assess patients' satisfaction with diabetes control and adherence to self-care regimen Patients (N = 10/12 or response rate = 83%) At end of the implementation period
SDOH Self-Efficacy SDOH Self-Efficacy survey (created for study, alpha = 0.94) (5 items; 5-point scale, from “strongly disagree” to “strongly agree”) To assess confidence with SDOH needs being met and ability to problem-solve, access support and resources, and access medications
1

Venkatesh V, Bala H. Technology Acceptance Model 3 and a Research Agenda on Interventions Subject Areas: Design Characteristics, Interventions. Decis Sci [Internet]. 2008;39(2):273–315. doi.org/10.1111/j.1540-5915.2008.00192.x

2

Livet M, Blanchard C, Richard C, et al. Measuring implementation of medication optimization services: Development and validation of an implementation outcomes questionnaire. Res Soc Adm Pharm. 2021 (December 2020). doi.org/10.1016/j.sapharm.2021.01.001

3

Shin J, Moczygemba LR, Barner JC, Garza A, Linedecker-Smith S, Srinivasa M. Patient experience with clinical pharmacist services in Travis County Federally Qualified Health Centers. Pharmacy Practice 2020 (Apr-Jun);18(2):1751. doi.org/10.18549/PharmPract.2020.2.1751

4

Burroughs J, Mick D. Exploring Antecedents and Consequences of Consumer Creativity in a Problem-Solving Context, Journal of Consumer Research. 2004;31(2):402–411. doi.org/10.1086/422118